293 related articles for article (PubMed ID: 20837752)
1. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Cui L; Isii T; Fukuda M; Ochiai T; Neoh HM; Camargo IL; Watanabe Y; Shoji M; Hishinuma T; Hiramatsu K
Antimicrob Agents Chemother; 2010 Dec; 54(12):5222-33. PubMed ID: 20837752
[TBL] [Abstract][Full Text] [Related]
2. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.
Camargo IL; Neoh HM; Cui L; Hiramatsu K
Antimicrob Agents Chemother; 2008 Dec; 52(12):4289-99. PubMed ID: 18824611
[TBL] [Abstract][Full Text] [Related]
3. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
Bæk KT; Thøgersen L; Mogenssen RG; Mellergaard M; Thomsen LE; Petersen A; Skov S; Cameron DR; Peleg AY; Frees D
Antimicrob Agents Chemother; 2015 Nov; 59(11):6983-91. PubMed ID: 26324273
[TBL] [Abstract][Full Text] [Related]
4. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.
Passalacqua KD; Satola SW; Crispell EK; Read TD
Antimicrob Agents Chemother; 2012 Oct; 56(10):5212-23. PubMed ID: 22850507
[TBL] [Abstract][Full Text] [Related]
5. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
6. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
Cafiso V; Bertuccio T; Spina D; Purrello S; Campanile F; Di Pietro C; Purrello M; Stefani S
PLoS One; 2012; 7(1):e29573. PubMed ID: 22253738
[TBL] [Abstract][Full Text] [Related]
7. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
[TBL] [Abstract][Full Text] [Related]
8. "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
Saito M; Katayama Y; Hishinuma T; Iwamoto A; Aiba Y; Kuwahara-Arai K; Cui L; Matsuo M; Aritaka N; Hiramatsu K
Antimicrob Agents Chemother; 2014 Sep; 58(9):5024-35. PubMed ID: 24841271
[TBL] [Abstract][Full Text] [Related]
9. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3.
Matsuo M; Hishinuma T; Katayama Y; Cui L; Kapi M; Hiramatsu K
Antimicrob Agents Chemother; 2011 Sep; 55(9):4188-95. PubMed ID: 21746940
[TBL] [Abstract][Full Text] [Related]
10. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
[TBL] [Abstract][Full Text] [Related]
11. A mutation of RNA polymerase β' subunit (RpoC) converts heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) into "slow VISA".
Matsuo M; Hishinuma T; Katayama Y; Hiramatsu K
Antimicrob Agents Chemother; 2015 Jul; 59(7):4215-25. PubMed ID: 25941225
[TBL] [Abstract][Full Text] [Related]
12. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA).
Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L
Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin and vancomycin heteroresistance revealed among CC5-SCCmecII MRSA clone and in vitro evaluation of treatment alternatives.
Okado JB; Avaca-Crusca JS; Oliveira AL; Dabul ANG; Camargo ILBDC
J Glob Antimicrob Resist; 2018 Sep; 14():209-216. PubMed ID: 29753135
[TBL] [Abstract][Full Text] [Related]
14. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
Neoh HM; Cui L; Yuzawa H; Takeuchi F; Matsuo M; Hiramatsu K
Antimicrob Agents Chemother; 2008 Jan; 52(1):45-53. PubMed ID: 17954695
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
Matsuo M; Cui L; Kim J; Hiramatsu K
Antimicrob Agents Chemother; 2013 Dec; 57(12):5843-53. PubMed ID: 24018261
[TBL] [Abstract][Full Text] [Related]
16. Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.
Vidaillac C; Gardete S; Tewhey R; Sakoulas G; Kaatz GW; Rose WE; Tomasz A; Rybak MJ
J Infect Dis; 2013 Jul; 208(1):67-74. PubMed ID: 23539745
[TBL] [Abstract][Full Text] [Related]
17. Evolution and single-nucleotide polymorphisms in methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to vancomycin and daptomycin, based on determination of the complete genome.
Yamaguchi T; Suzuki S; Okamura S; Miura Y; Tsukimori A; Nakamura I; Ito N; Masuya A; Shiina T; Matsumoto T
Antimicrob Agents Chemother; 2015; 59(6):3585-7. PubMed ID: 25779584
[TBL] [Abstract][Full Text] [Related]
18. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
Cui L; Tominaga E; Neoh HM; Hiramatsu K
Antimicrob Agents Chemother; 2006 Mar; 50(3):1079-82. PubMed ID: 16495273
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.
Kang KM; Mishra NN; Park KT; Lee GY; Park YH; Bayer AS; Yang SJ
J Microbiol; 2017 Feb; 55(2):153-159. PubMed ID: 28120188
[TBL] [Abstract][Full Text] [Related]
20. An induced mutation of ABC-transporter component VraF(K84E) contributes to vancomycin resistance and virulence in Staphylococcus aureus strain MW2.
Cao R; Su H; Wei Z; He Z; Pan T; Li Y; Sun B
Int J Med Microbiol; 2024 Jun; 315():151624. PubMed ID: 38838390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
